Medication info
Losartan 100 mg (Losartan Potassium)

Losartan 100 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tablet
Manufacturer / importer
Ildong Pharmaceutical Co., Ltd.
Appearance
White, drop-shaped film-coated tablets
Packaging
30 tablets, 300 tablets/bottle
Approval status
Active

MFDS item code 200711953 · Notified 2007.10.31 · Insurance code 642900320

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with other antihypertensive drugs (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily; this may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; this may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
Ildong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease
View approved original text

This medication is used to treat hypertension and is particularly helpful in slowing the progression of kidney disease in patients with both hypertension and type 2 diabetes. Therefore, it is effective in maintaining stable blood pressure and protecting kidney function.

How to take

Adult dose

This drug may be taken with or without food, but it is recommended that it be taken at the same time each day. Hypertension - Adults: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with other antihypertensive drugs (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this drug once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This drug may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this drug once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this drug once daily is recommended. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics), an initial dose of 25 mg of this drug once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this drug once daily; this may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this drug once daily; this may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, women who are pregnant or may become pregnant should not take it. If pregnancy is confirmed, this medication should be discontinued as soon as possible, and regular ultrasound examinations may be required to monitor the health of the fetus. This medication should not be administered to patients with severely impaired liver function or hereditary angioedema, or primary hyperaldosteronism. Additionally, this medication contains lactose, so patients with lactose intolerance should avoid it. Caution is required when administering to elderly patients, those with decreased kidney function, and patients with hyperkalemia, as there is a risk of rapid drops in blood pressure, and careful monitoring is necessary. Blood pressure, serum potassium levels, and kidney function should be regularly tested during treatment, and if any unusual symptoms occur, immediate consultation with healthcare professionals is advised. Particularly, when taken together with potassium-sparing diuretics or potassium supplements, the potassium levels in the blood may dangerously increase, so combination therapy should be avoided. This medication may rarely cause side effects such as angioedema, hepatitis, muscle pain, hypotension, or renal failure, and if symptoms are suspected, immediate treatment is required. Dizziness or orthostatic hypotension may occur during treatment, so caution is needed when driving or operating machinery. Additionally, interactions may occur when taken with other antihypertensive medications or non-steroidal anti-inflammatory drugs (NSAIDs), so it is essential to inform healthcare professionals of any other medications being taken. Grapefruit juice may decrease the effectiveness of this medication, so it is advisable to avoid consuming it together. This medication is not recommended for breastfeeding women; if it must be taken, stopping breastfeeding is advisable. It should not be administered to children under 6 years of age or to children and adolescents with severe kidney impairment. In the case of overdose, hypotension and bradycardia may occur, so it is important to strictly adhere to the dosing schedule and inform healthcare professionals of any unusual symptoms immediately. Keep this medication out of the reach of children and do not transfer it to another container for safety.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • back pain
  • limb pain
  • dizziness
  • congestion
Show 130 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • loss of appetite
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • myasthenia
  • arthralgia
  • arthritis
  • fibromyalgia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • nervous hypersensitivity
  • sensory anomalies
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • nasal bleeding
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • itching
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactic syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • malaise
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disturbance
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased BUN
  • increased serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • atrial fibrillation
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White, drop-shaped film-coated tablets

Package unit

30 tablets, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.